Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Chemotherapy options and new advances in malignant pleural mesothelioma Steele JP; Klabatsa AAnn Oncol 2005[Mar]; 16 (3): 345-51Malignant pleural mesothelioma continues to be a challenging clinical problem. While traditionally, chemotherapy has been thought to be of only modest benefit to patients with this disease, novel antineoplastic agents and combination regimens incorporating these agents are gradually changing this perception. Early attempts at treatment and palliation with single agents such as doxorubicin met with low response rates and little clinical benefit. However, the recently reported clinical benefits of pemetrexed and raltitrexed in combination with cisplatin are changing the perception about the ability of chemotherapy to affect the natural history of the disease. Other combinations, including cisplatin and gemcitabine, have also shown encouraging response rates and clinical activity. Single-agent therapy with vinorelbine may provide useful palliation with low toxicity. Targeted agents developed through increased understanding of the biology of the disease, used alone or as part of multimodal therapy, may provide major clinical gains in the next few years.|Antineoplastic Combined Chemotherapy Protocols/*therapeutic use[MESH]|Cisplatin/administration & dosage[MESH]|Deoxycytidine/administration & dosage/*analogs & derivatives[MESH]|Gemcitabine[MESH]|Glutamates/administration & dosage[MESH]|Guanine/administration & dosage/*analogs & derivatives[MESH]|Humans[MESH]|Mesothelioma/*drug therapy/pathology[MESH]|Palliative Care[MESH]|Pemetrexed[MESH]|Pleural Neoplasms/*drug therapy/pathology[MESH]|Prognosis[MESH]|Quinazolines/administration & dosage[MESH]|Randomized Controlled Trials as Topic[MESH]|Thiophenes/administration & dosage[MESH] |
